{"id":"W2547646848","doi":"10.1016/j.rmed.2016.11.001","title":"Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors","year":2016,"lang":"en","type":"article","venue":"Respiratory Medicine","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Bayer HealthCare; United Therapeutics Corporation; Gilead Sciences; GlaxoSmithKline; Pfizer; Ikaria; Eli Lilly and Company","keywords":"Riociguat; Medicine; Sildenafil; cGMP-specific phosphodiesterase type 5; Cyclic guanosine monophosphate; Internal medicine; Pulmonary hypertension; Tadalafil; Cardiology; Chronic thromboembolic pulmonary hypertension; Nitric oxide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001143459,0.0003979777,0.001038419,0.0006142876,0.0001255105,0.00001475194,0.0001838715,0.00007279092,0.00003103114],"category_scores_gemma":[0.000206277,0.0001987394,0.00001296259,0.0005803244,0.000277942,0.0003708146,0.00009761113,0.000102806,0.000001822063],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001888317,"about_ca_system_score_gemma":0.0004397693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002340736,"about_ca_topic_score_gemma":0.0001460087,"domain_scores_codex":[0.9958313,0.001152146,0.0007809812,0.0008023644,0.001061438,0.0003718147],"domain_scores_gemma":[0.9974146,0.0003321575,0.0002495513,0.0008021985,0.0005710101,0.0006304206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2975418,0.1113409,0.3922674,0.00002734859,0.0002664402,0.003404724,0.00222855,0.00001145911,0.1642207,7.192616e-7,0.00004621447,0.02864381],"study_design_scores_gemma":[0.1087724,0.3910596,0.4936532,0.0006635707,0.0002027062,0.00002887741,0.00277031,0.00004916899,0.002521389,0.000001753924,0.00008605207,0.0001909885],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991286,0.0001618839,0.00001823282,0.0002496837,0.00004326813,0.008163217,0.00004807529,0.00001955517,0.00001001586],"genre_scores_gemma":[0.9991273,0.00001844054,0.0001918111,0.0001789451,0.00004521738,0.0003188611,0.00002231093,0.00004614407,0.00005094627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2797187,"threshold_uncertainty_score":0.8104356,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0877483271850614,"score_gpt":0.3468517795948621,"score_spread":0.2591034524098007,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}